Proctofoam-HC 1%-1% foam 10GM
Ended Awarded
- Contract number
- SPE2DB25FTWM4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,254
Award facts
- Contract value 100% obligated
- $4,253.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,253.70 to DMS Pharmaceutical Group Inc. for Proctofoam-HC 1%-1% Foam in 10-gram quantities. The contract, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This award represents a discrete order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and extending through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of contracts with the Defense Logistics Agency. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide. Proctofoam-HC is a topical foam medication used in treating hemorrhoids and anal fissures, representing a routine pharmaceutical delivery consistent with the company's core business of providing essential medical supplies to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FTWM4?
SPE2DB25FTWM4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWM4 worth?
The government has obligated $4,254 on SPE2DB25FTWM4.
Is contract SPE2DB25FTWM4 an order under another contract?
Yes. SPE2DB25FTWM4 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWM4 competed?
The extent of competition for SPE2DB25FTWM4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award